Harmonicare Medical Holdings Limited provided consolidated earnings guidance for the year ended 31 December 2018. For the period, based on the preliminary assessment of the unaudited consolidated management accounts of the Group, the company expects that it will record a significant net loss for the Current Period, as compared to a net profit recorded for the year ended 31 December 2017. Such expected loss is mainly attributable to: a great amount of administrative expenses incurred during the Current Period due to some new hospitals of the Group being at the later stages of construction; losses incurred from the newly-acquired Baiziwan HarMoniCare Hospital during the Current Period; losses incurred from some existing hospitals of the Group during the Current Period due to the decreasing number of newborns in China and the intensifying competition in the industry, as well as the continuous increase of expenses such as labor costs and advertising fees; and losses incurred from investments in associates during the Current Period, due to the upstream and downstream businesses the Group invested in still being at development stages.